Alector (ALEC) Price to FCF (2019 - 2026)
Alector's (ALEC) quarterly Price to FCF came in at 6.55 in Q2 2026, down 126.87% year-over-year from 24.39 in Q2 2025, and down 37.07% quarter-over-quarter from 4.78 in Q1 2026.
Analysis
Alector (ALEC) Price to FCF (2019 - 2026) Analysis & Trends
Alector (ALEC) has reported Price to FCF for 8 consecutive years, with 6.55 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Price to FCF fell 126.87% year-over-year to 6.55 in Q2 2026; TTM through Jun 2026 was 1.42, a 116.0% decrease from a year earlier, with the FY2025 full-year figure at 0.94, down 15.45% from the prior year.
- Price to FCF was 6.55 for Q2 2026 at Alector, down from 4.78 in the prior quarter.
- Over five years, Price to FCF peaked at 8.69 in Q1 2022 and troughed at 15.4 in Q4 2022.
- A 5-year average of 7.96 and a median of 9.17 in 2024 frame the typical range for Price to FCF.
- The widest YoY moves for Price to FCF: up 129.04% in 2022, down 473.4% in 2022.
- Over 5 years, Price to FCF stood at 15.4 in 2022, then advanced by 5.0% to 14.63 in 2023, then surged by 76.81% to 3.39 in 2024, then fell by 21.72% to 4.13 in 2025, then tumbled by 58.69% to 6.55 in 2026.
- The last three Price to FCF figures came in at 6.55 (Q2 2026), 4.78 (Q1 2026), and 4.13 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.55 |
| Mar 31, 2026 | -4.78 |
| Dec 31, 2025 | -4.13 |
| Sep 30, 2025 | -9.78 |
| Jun 30, 2025 | -2.89 |
| Mar 31, 2025 | -2.02 |
| Dec 31, 2024 | -3.39 |
| Sep 30, 2024 | -8.96 |
| Jun 30, 2024 | -7.00 |
| Mar 31, 2024 | -9.38 |
| Dec 31, 2023 | -14.63 |
| Sep 30, 2023 | -11.74 |
| Jun 30, 2023 | -11.39 |
| Mar 31, 2023 | -10.41 |
| Dec 31, 2022 | -15.40 |
| Sep 30, 2022 | -15.22 |
| Jun 30, 2022 | -14.32 |
| Mar 31, 2022 | 8.69 |
| Dec 31, 2021 | -33.98 |
| Sep 30, 2021 | 4.08 |